Abstract Purpose of Review This review provides an update on rheumatic mitral stenosis.
Acute rheumatic fever (RF), the sequela of group A β-hemolytic streptococcal infection, is the …

Although the prevalence of rheumatic fever is decreasing in developed countries, it still
affects numerous areas in the nonindustrialized world. Untreated mitral stenosis (MS) …

Background—Current echocardiographic scoring systems for percutaneous mitral
valvuloplasty (PMV) have limitations. This study examined new, more quantitative methods …

Objectives The aim of this study was to assess the incidence, mechanisms, and outcomes of
mitral regurgitation (MR) after percutaneous mitral valvuloplasty (PMV). Background …

Mitral regurgitation (MR) is one of the most prevalent valvular pathologies in the developed
world. There continues to be a growing population of aging patients with MR who may be …

Percutaneous mitral commissurotomy (PMC) is the first-line therapy for managing rheumatic
mitral stenosis. Over the past two decades, the indications of the procedure have expanded …

Objective Implantation of a transcatheter valve-in-mitral annular calcification (ViMAC) has
emerged as an alternative to traditional surgical mitral valve (MV) replacement. Previous …

Aim Patients with severe mitral stenosis (MS) and their clinicians typically choose
percutaneous transvenous mitral commissurotomy (PTMC) over surgical commissurotomy …

TEE is routinely used to guide percutaneous interventions involving the MV. The most
common percutaneous procedures are (1) percutaneous mitral balloon valvuloplasty …

Background: Percutaneous balloon mitral valvuloplasty is the preferred therapeutic strategy
in patients with mitral stenosis, but it has shortcomings in a subset of patients. Hypothesis: A …